Lyon Joseph Douglas has demonstrated a clear selling bias in his recent transactions involving Corcept Therapeutics (CORT), with no recorded purchases in his last 11 reported trades. Since July 2025, Douglas has executed multiple sales, including a $284,863.74 disposition on July 17, 2025, followed by a $393,127.62 sale on August 1, 2025. The pattern intensified toward the end of 2025, with two large transactions on December 1 totaling $397,631.50 in sales alongside $142,00.84 in derivative acquisitions. Notably, his most recent activity in March 2026 included a $14,316.06 derivative acquisition on March 2, followed by a $3,201.33 sale the next day.
Over the observed period, Douglas’s transactions reflect a net reduction in his CORT holdings, with total sales exceeding $2.26 million against $449,592.90 in buys. The sales were often paired with smaller derivative transactions, such as option exercises (coded "M") and awards (coded "A"), suggesting a methodical unwinding of positions. The largest single sale occurred on December 1, 2025, while the most recent activity in early March 2026 indicates continued, albeit smaller, disposals. Douglas’s trading history is confined to CORT, with no activity in other securities disclosed in the filings. The absence of recent buys and the consistency of sales point to a sustained divestment trend.
AI-assisted summary